3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
4
Phase EARLY_PHASE1
1
Phase 3
1
Phase 2/3
1
Phase 1/2
1
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Large B-Cell, Diffuse
8
Sarcoma
7
Osteosarcoma
4
Lymphoma
4
Wilms Tumor
3
Neuroectodermal Tumors, Primitive, Peripheral
3
Neuroblastoma
3
Neoplasms
3
Carcinoma, Renal Cell
3
Unspecified Adult Solid Tumor, Protocol Specific
2
Retinoblastoma
2
Optic Nerve Glioma
2
Melanoma
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Hodgkin Disease
2
Carcinoma, Hepatocellular
2
Astrocytoma
2
Waldenstrom Macroglobulinemia
1
Uveal Melanoma
1
Thrombocytopenia
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Solid Tumors
1
Sarcoma, Synovial
1
Sarcoma, Ewing
1
Sarcoma, Alveolar Soft Part
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Interventions
Cyclophosphamide
38
fludarabine
30
Rituximab
26
obinutuzumab
10
Bendamustine Hydrochloride
10
fludarabine phosphate
9
pembrolizumab
8
Specimen Handling
7
Etoposide
7
venetoclax
6
Vincristine
6
Prednisone
6
Magnetic Resonance Spectroscopy
6
Leukapheresis
6
Lenalidomide
6
ibrutinib
5
Inotuzumab Ozogamicin
5
Immunotherapy, Adoptive
5
Doxorubicin
5
Biopsy
5
ublituximab
4
tazemetostat
4
glofitamab
4
Interleukin-2
4
Dexamethasone
4
Cytarabine
4
pomalidomide
3
polatuzumab vedotin
3
Radiation
3
Nivolumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Lymphoma, B-Cell
×
Ifosfamide
×
Clear all
NCT01300793
2012-09-26
V-RICE
University of California, San Francisco
Phase 1
Terminated
6 enrolled